How metabolic disorders affect liver cirrhosis outcomes
Part of Hormones & metabolism clinical trials.
This study looks at how conditions like diabetes and obesity affect people with advanced liver scarring (cirrhosis). By understanding these connections, researchers hope to better predict and manage complications in cirrhosis patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have liver cirrhosis confirmed by imaging (ultrasound, CT, or MRI) or a liver biopsy showing advanced scarring, or a stiffness measurement showing significant scarring
- Your cirrhosis is stable (no recent bleeding from enlarged veins, significant fluid buildup in the belly, or severe confusion from liver disease)
- You have not had liver cancer or other untreatable cancers, and you are not expected to die within one year
- You do not have severe heart, lung, brain, or kidney disease
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is building a model to better predict how metabolic liver disease (MASLD) that has led to cirrhosis (scarring of the liver) will progress. If you have compensated cirrhosis (your liver is still working well) and have been diagnosed with MASLD or a related condition, this research could help develop more personalized care.
This study looks at how nutrition affects the health of people with liver cirrhosis (scarred liver) and aims to build a tool to predict their outcomes. If you have cirrhosis, joining may help researchers find better ways to support your health.
This study is looking at how cirrhosis affects the heart (called cirrhotic cardiomyopathy). It aims to understand the connection between advanced liver disease and heart function, which may help improve care for people with cirrhosis.
This study compares two treatments for liver scarring in people with overweight or related health issues. One group follows a special diet with restricted eating times, while the other takes a combination of two medications (naltrexone and bupropion). It aims to see which approach better improves liver fibrosis.
This study looks at how to predict future outcomes in adults who have fatty-liver disease (NAFLD) that has progressed to cirrhosis. It may help doctors better estimate risk and plan care, using information from liver tests and scans.
This study tests strategies to prevent cirrhosis in people with metabolic fatty liver disease and early to moderate liver scarring. It aims to find better ways to stop liver damage from getting worse.
Hear when a new Compensated Advanced Chronic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.